KYMERA THERAPEUTICS, INC. (KYMR) /
The profitability of KYMERA THERAPEUTICS, INC. over the past 7 years
Chart KYMERA THERAPEUTICS, INC.: gross profit, operating income, net income, fiscal 2019–2025 Open the chart →KYMERA THERAPEUTICS, INC. reported a net loss of $311.35M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $0 and an operating loss of $349.4M. It reported a loss in all 7 years shown.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $0* | -$349.4M | -$311.35M |
| 2024ended Dec 31, 2024 | $0* | -$261.63M | -$223.86M |
| 2023ended Dec 31, 2023 | $0* | -$165.53M | -$146.96M |
| 2022ended Dec 31, 2022 | $0* | -$161.26M | -$154.81M |
| 2021ended Dec 31, 2021 | — | -$100.53M | -$100.22M |
| 2020ended Dec 31, 2020 | — | -$46.3M | -$45.59M |
| 2019ended Dec 31, 2019 | — | -$42.2M | -$41.25M |
Fiscal years as KYMERA THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on KYMERA THERAPEUTICS, INC.
- The revenue of KYMERA THERAPEUTICS, INC.
- The cash flow of KYMERA THERAPEUTICS, INC.
- The debt of KYMERA THERAPEUTICS, INC.
- All of KYMERA THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- DDSDILLARD’S, INC.
- HIIHUNTINGTON INGALLS INDUSTRIES, INC.
- ARWARROW ELECTRONICS, INC.
- FNFFIDELITY NATIONAL FINANCIAL, INC.
- BMRNBIOMARIN PHARMACEUTICAL INC
Not investment advice. This page shows what KYMERA THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.